229 POSTER Combination effects of SF1126, a vascular targeted PI3 kinase inhibitor, with herceptin in Her-2 overexpressing breast cancer cells
N. Alami, Y. Sun, P. De, D.L. Durden, B. Leyland-JonesVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72161-x
File:
PDF, 59 KB
english, 2008